Clinical Trial Update: Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of forodesine in relapsed B-cell chronic lymphocytic leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Forodesine (forodesine)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: B-cell Chronic Lymphocytic Leukemia | Phase 1 | Status: TERMINATED